Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Astera Labs, Inc.ALAB · Entity 1853 | Director | October 01, 2026 | October 09, 2026 |
| FINISAR CORPFNSR · Entity 154739 | Director · CEO | August 02, 2019 | August 06, 2019 |
| FLEX LTD.FLEX · Entity 3085 | Director | August 05, 2026 | August 08, 2026 |
| Lumentum Holdings Inc.LITE · Entity 2957 | Director · President and CEO | August 25, 2026 | August 28, 2026 |
| SYNAPTICS IncSYNA · Entity 4089 | Director · See Remarks | November 17, 2024 | November 19, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Astera Labs, Inc.
Report date October 01, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 92,554 |
Reported balance
After 2026-10-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 72 · Balance 92,554 F1: These shares represent an award of restricted stock units ("RSUs") granted on October 1, 2026, under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan in lieu of cash compensation for quarterly non-employee director retainer fees pursuant to the Reporting Person's election. The award provides that 100% of the RSUs will vest on the three-month anniversary of the Vesting Commencement Date of August 15, 2026, subject to the Reporting Person's continuous service relationship with the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2: Includes deferred stock units and dividend equivalent units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent an award of restricted stock units ("RSUs") granted on October 1, 2026, under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan in lieu of cash compensation for quarterly non-employee director retainer fees pursuant to the Reporting Person's election. The award provides that 100% of the RSUs will vest on the three-month anniversary of the Vesting Commencement Date of August 15, 2026, subject to the Reporting Person's continuous service relationship with the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: Includes deferred stock units and dividend equivalent units.
FINISAR CORP
Report date August 02, 2019 · Filed August 06, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 257,564 |
Ending reported balance
After 2019-08-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-08-02 · Exercise / conversion · Acquired 3,125 · Balance 259,114 F1: On August 2, 2019, the Reporting Person vested in 3,125 performance restricted stock units ("PSUs") and as a result acquired 3,125 shares of common stock of the Issuer pursuant to the Reporting Person's June 19, 2018 grant of PSUs. This Form 4 also reports shares withheld by the Issuer pursuant to the PSUs' grant agreement in order to satisfy the Reporting Person's withholding obligations for various taxes due upon the vesting of the PSUs. No shares were sold by the Reporting Person. The Issuer will pay the taxes on behalf of the Reporting Person. Row 2 · 2019-08-02 · Tax withholding · Disposed 1,550 · Balance 257,564 F1: On August 2, 2019, the Reporting Person vested in 3,125 performance restricted stock units ("PSUs") and as a result acquired 3,125 shares of common stock of the Issuer pursuant to the Reporting Person's June 19, 2018 grant of PSUs. This Form 4 also reports shares withheld by the Issuer pursuant to the PSUs' grant agreement in order to satisfy the Reporting Person's withholding obligations for various taxes due upon the vesting of the PSUs. No shares were sold by the Reporting Person. The Issuer will pay the taxes on behalf of the Reporting Person. |
| Performance Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2022-05-06 | Direct | 134,375 |
Reported balance
After 2019-08-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-08-02 · Exercise / conversion · Disposed 3,125 · Balance 134,375 F1: On August 2, 2019, the Reporting Person vested in 3,125 performance restricted stock units ("PSUs") and as a result acquired 3,125 shares of common stock of the Issuer pursuant to the Reporting Person's June 19, 2018 grant of PSUs. This Form 4 also reports shares withheld by the Issuer pursuant to the PSUs' grant agreement in order to satisfy the Reporting Person's withholding obligations for various taxes due upon the vesting of the PSUs. No shares were sold by the Reporting Person. The Issuer will pay the taxes on behalf of the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 2, 2019, the Reporting Person vested in 3,125 performance restricted stock units ("PSUs") and as a result acquired 3,125 shares of common stock of the Issuer pursuant to the Reporting Person's June 19, 2018 grant of PSUs. This Form 4 also reports shares withheld by the Issuer pursuant to the PSUs' grant agreement in order to satisfy the Reporting Person's withholding obligations for various taxes due upon the vesting of the PSUs. No shares were sold by the Reporting Person. The Issuer will pay the taxes on behalf of the Reporting Person.
FLEX LTD.
Report date August 05, 2026 · Filed August 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 61,286 |
Reported balance
After 2026-08-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-05 · Grant · Acquired 1,928 · Balance 61,286 F1: On August 5, 2026, the Reporting Person was awarded a total of 1,928 restricted share units ("RSUs") pursuant to the terms of the annual equity award to Non-Employee Directors under the Issuer's Amended and Restated 2017 Equity Incentive Plan as more fully described in the section titled "Fiscal Year 2026 Non-Employee Directors' Compensation" beginning on page 24 of the Issuer's Proxy Statement filed with the SEC on June 24, 2026. Each RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not previously forfeited. The award shall vest in full on the date immediately prior to the date of the Issuer's 2027 annual general meeting. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 61,696 |
Reported balance
After 2026-08-05 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-08-05 · Grant · Acquired 410 · Balance 61,696 F2: On August 5, 2026, the Reporting Person received a one-time special compensation equity award consisting of RSUs having an aggregate value of $50,000 which shall vest in full on the date immediately prior to the date of the Issuer's 2027 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. F3: Includes 2,338 unvested RSUs, which shall vest in full on the date immediately prior to the date of the Issuer's 2027 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 5, 2026, the Reporting Person was awarded a total of 1,928 restricted share units ("RSUs") pursuant to the terms of the annual equity award to Non-Employee Directors under the Issuer's Amended and Restated 2017 Equity Incentive Plan as more fully described in the section titled "Fiscal Year 2026 Non-Employee Directors' Compensation" beginning on page 24 of the Issuer's Proxy Statement filed with the SEC on June 24, 2026. Each RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not previously forfeited. The award shall vest in full on the date immediately prior to the date of the Issuer's 2027 annual general meeting.
F2: On August 5, 2026, the Reporting Person received a one-time special compensation equity award consisting of RSUs having an aggregate value of $50,000 which shall vest in full on the date immediately prior to the date of the Issuer's 2027 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited.
F3: Includes 2,338 unvested RSUs, which shall vest in full on the date immediately prior to the date of the Issuer's 2027 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited.
Lumentum Holdings Inc.
Report date August 25, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 186,951 |
Ending reported balance
After 2026-08-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-25 · Grant · Acquired 7,941 · Balance 187,499 F1: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, following vesting, one share of the Issuer's Common Stock. 1/3 of the shares shall vest one year from the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter on the 15th of November, February, May and August, subject to the Reporting Person continuing to be an employee through each such date, or as provided under the Issuer's 2025 Equity Incentive Plan. Row 2 · 2026-08-27 · Sale · Disposed 548 · Balance 186,951 F2: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, following vesting, one share of the Issuer's Common Stock. 1/3 of the shares shall vest one year from the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter on the 15th of November, February, May and August, subject to the Reporting Person continuing to be an employee through each such date, or as provided under the Issuer's 2025 Equity Incentive Plan.
F2: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026.
SYNAPTICS Inc
Report date November 17, 2024 · Filed November 19, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 453,815 |
Reported balance
After 2024-11-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-11-17 · Grant · Acquired 430 · Balance 453,815 F1: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2023. F2: Includes 49 shares acquired under the Issuer's Employee Stock Purchase Plan on September 15, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 449,509 |
Reported balance
After 2024-11-17 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2024-11-17 · Tax withholding · Disposed 4,306 · Balance 449,509 F3: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2023.
F2: Includes 49 shares acquired under the Issuer's Employee Stock Purchase Plan on September 15, 2024.
F3: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 9, 2026 23:20 UTC | Astera Labs, Inc. ALAB · Entity 1853 | GrantCommon Stock | 72 | $311.57 | $22,433.04 |
DisclosureSEC source: 0001573338-26-000019 · wk-form4_1791588027.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,554 F1 · shares: These shares represent an award of restricted stock units ("RSUs") granted on October 1, 2026, under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan in lieu of cash compensation for quarterly non-employee director retainer fees pursuant to the Reporting Person's election. The award provides that 100% of the RSUs will vest on the three-month anniversary of the Vesting Commencement Date of August 15, 2026, subject to the Reporting Person's continuous service relationship with the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes deferred stock units and dividend equivalent units. Read SEC document |
| August 27, 2026 Filed Aug 28, 2026 01:59 UTC | Lumentum Holdings Inc. LITE · Entity 2957 | SaleCommon Stock | 548 | $958.66 | $525,345.68 |
DisclosureSEC source: 0001573338-26-000017 · form4-08282026_010801.xml · nonDerivative · entry 2 HURLSTON MICHAEL E. · CIK 0001573338 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,951 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026. Read SEC document |
| August 25, 2026 Filed Aug 28, 2026 01:59 UTC | Lumentum Holdings Inc. LITE · Entity 2957 | GrantCommon Stock | 7,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001573338-26-000017 · form4-08282026_010801.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,499 F1 · kind: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, following vesting, one share of the Issuer's Common Stock. 1/3 of the shares shall vest one year from the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter on the 15th of November, February, May and August, subject to the Reporting Person continuing to be an employee through each such date, or as provided under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| August 19, 2026 Filed Aug 22, 2026 00:39 UTC | Lumentum Holdings Inc. LITE · Entity 2957 | Tax withholdingCommon Stock | 6,185 | $827.60 | $5,118,706.00 |
DisclosureSEC source: 0001573338-26-000015 · form4-08222026_120853.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,794 F1 · kind: Represents shares that have been withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 17, 2026 Filed Aug 28, 2026 01:58 UTC | Lumentum Holdings Inc. LITE · Entity 2957 | GrantCommon Stock | 66,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001573338-26-000016 · form4-08282026_010823.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,743 F1 · kind: The Compensation Committee of the Board of Directors of the Issuer certified achievement of certain performance conditions with respect to performance stock units (PSUs) granted to the Reporting Person on August 19, 2025. The PSUs remain subject to time-based vesting; 100% of the shares shall vest on August 19, 2028, subject to the Reporting Person continuing to be a service provider of the Issuer through such date. F2 · balance_after: The number of shares reported as beneficially owned following the reported transaction is as of August 17, 2026. Read SEC document |
| August 15, 2026 Filed Aug 19, 2026 00:43 UTC | Lumentum Holdings Inc. LITE · Entity 2957 | Tax withholdingCommon Stock | 5,438 | $926.14 | $5,036,349.32 |
DisclosureSEC source: 0001573338-26-000014 · form4-08192026_120840.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,979 F1 · kind: Represents shares that have been withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 05, 2026 Filed Aug 8, 2026 00:36 UTC | FLEX LTD. FLEX · Entity 3085 | GrantOrdinary Shares | 410 | $0.00 | $0.00 |
DisclosureSEC source: 0001573338-26-000013 · wk-form4_1786149400.xml · nonDerivative · entry 2 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,696 F2 · shares: On August 5, 2026, the Reporting Person received a one-time special compensation equity award consisting of RSUs having an aggregate value of $50,000 which shall vest in full on the date immediately prior to the date of the Issuer's 2027 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. F3 · balance_after: Includes 2,338 unvested RSUs, which shall vest in full on the date immediately prior to the date of the Issuer's 2027 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. Read SEC document |
| August 05, 2026 Filed Aug 8, 2026 00:36 UTC | FLEX LTD. FLEX · Entity 3085 | GrantOrdinary Shares | 1,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001573338-26-000013 · wk-form4_1786149400.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,286 F1 · shares: On August 5, 2026, the Reporting Person was awarded a total of 1,928 restricted share units ("RSUs") pursuant to the terms of the annual equity award to Non-Employee Directors under the Issuer's Amended and Restated 2017 Equity Incentive Plan as more fully described in the section titled "Fiscal Year 2026 Non-Employee Directors' Compensation" beginning on page 24 of the Issuer's Proxy Statement filed with the SEC on June 24, 2026. Each RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not previously forfeited. The award shall vest in full on the date immediately prior to the date of the Issuer's 2027 annual general meeting. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 00:43 UTC | FLEX LTD. FLEX · Entity 3085 | GrantOrdinary Shares | 174 | $0.00 | $0.00 |
DisclosureSEC source: 0001573338-26-000011 · wk-form4_1784335413.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,358 F1 · shares: On July 15, 2026, the Reporting Person was awarded a total of 174 restricted share units ("RSUs") pursuant to the terms of the Issuer's Share Election Program whereby directors elect to receive equity in lieu of cash compensation and as approved by Issuer's Board of Directors and Shareholders on 7/24/2013 and 7/29/2013, respectively. The award was granted for the quarterly period from 04/01/2026 to 06/30/2026. The award vested immediately upon grant. F2 · balance_after: Includes 4,713 unvested RSUs, which vest in full on the date immediately prior to the date of Issuer's 2026 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. Read SEC document |
| June 04, 2026 Filed Jun 9, 2026 00:23 UTC | Astera Labs, Inc. ALAB · Entity 1853 | GrantCommon Stock | 837 | $0.00 | $0.00 |
DisclosureSEC source: 0001573338-26-000009 · wk-form4_1780964598.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,482 F1 · shares: These shares represent an award of restricted stock units ("RSUs") granted on June 4, 2026 (the "Grant Date") under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award vests in full upon the earlier of (i) the first anniversary of the Grant Date or (ii) the date of the next annual stockholder meeting of the Company following the Grant Date, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F2 · balance_after: Includes deferred stock units and dividend equivalent units. Read SEC document |
| May 15, 2026 Filed May 20, 2026 00:05 UTC | Lumentum Holdings Inc. LITE · Entity 2957 | Tax withholdingCommon Stock | 5,438 | $970.70 | $5,278,666.60 |
DisclosureSEC source: 0001573338-26-000006 · form4-05202026_120544.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,417 F1 · kind: Represents shares that have been withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting of restricted stock units. F2 · balance_after: Includes 107 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 15, 2026. Read SEC document |
| April 15, 2026 Filed Apr 18, 2026 01:32 UTC | FLEX LTD. FLEX · Entity 3085 | GrantOrdinary Shares | 286 | $0.00 | $0.00 |
DisclosureSEC source: 0001573338-26-000005 · wk-form4_1776475929.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,184 F1 · shares: On April 15, 2026, the Reporting Person was awarded a total of 286 restricted share units ("RSUs") pursuant to the terms of the Issuer's Share Election Program whereby directors elect to receive equity in lieu of cash compensation and as approved by Issuer's Board of Directors and Shareholders on 7/24/2013 and 7/29/2013, respectively. The award was granted for the quarterly period from 01/01/2026 to 03/31/2026. The award vested immediately upon grant. F2 · balance_after: Includes 4,713 unvested RSUs, which vest in full on the date immediately prior to the date of Issuer's 2026 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. Read SEC document |
| February 07, 2026 Filed Feb 10, 2026 22:26 UTC | Lumentum Holdings Inc. LITE · Entity 2957 | Tax withholdingCommon Stock | 20,169 | $551.99 | $11,133,086.31 |
DisclosureSEC source: 0001573338-26-000003 · form4-02102026_100217.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,748 F1 · kind: Represents shares that have been withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting of restricted stock units. F2 · balance_after: Includes 320 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 14, 2025. Read SEC document |
| January 15, 2026 Filed Jan 17, 2026 01:51 UTC | FLEX LTD. FLEX · Entity 3085 | GrantOrdinary Shares | 337 | $0.00 | $0.00 |
DisclosureSEC source: 0001573338-26-000002 · wk-form4_1768614689.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,898 F1 · shares: On January 15, 2026, the Reporting Person was awarded a total of 337 restricted share units ("RSUs") pursuant to the terms of the Issuer's Share Election Program whereby directors elect to receive equity in lieu of cash compensation and as approved by Issuer's Board of Directors and Shareholders on 7/24/2013 and 7/29/2013, respectively. The award was granted for the quarterly period from 10/01/2025 to 12/31/2025. The award vested immediately upon grant. F2 · balance_after: Includes 4,713 unvested RSUs, which vest in full on the date immediately prior to the date of Issuer's 2026 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. Read SEC document |
| November 26, 2025 Filed Nov 27, 2025 01:20 UTC | FLEX LTD. FLEX · Entity 3085 | SaleOrdinary Shares | 10,000 | $58.00 | $580,000.00 |
DisclosureSEC source: 0001573338-25-000011 · wk-form4_1764206416.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,561 F1 · balance_after: Includes 4,713 unvested restricted share units ("RSUs"), which vest in full on the date immediately prior to the date of Issuer's 2026 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. Read SEC document |
| November 20, 2025 Filed Nov 25, 2025 02:19 UTC | FLEX LTD. FLEX · Entity 3085 | SaleOrdinary Shares | 10,000 | $56.17 | $561,692.00 |
DisclosureSEC source: 0001573338-25-000009 · wk-form4_1764037137.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,561 F1 · price: Price reflects weighted average sales price; actual sales prices ranged from $56.15 to $56.25. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · balance_after: Includes 4,713 unvested restricted share units ("RSUs"), which vest in full on the date immediately prior to the date of Issuer's 2026 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. Read SEC document |
| October 15, 2025 Filed Oct 18, 2025 00:52 UTC | FLEX LTD. FLEX · Entity 3085 | GrantOrdinary Shares | 353 | $0.00 | $0.00 |
DisclosureSEC source: 0001573338-25-000007 · wk-form4_1760748736.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,561 F1 · shares: On October 15, 2025, the Reporting Person was awarded a total of 353 restricted share units ("RSUs") pursuant to the terms of the Issuer's Share Election Program whereby directors elect to receive equity in lieu of cash compensation and as approved by Issuer's Board of Directors and Shareholders on 7/24/2013 and 7/29/2013, respectively. The award was granted for the quarterly period from 07/01/2025 to 09/30/2025. The award vested immediately upon grant. F2 · balance_after: Includes 4,713 unvested RSUs, which vest in full on the date immediately prior to the date of Issuer's 2026 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. Read SEC document |
| August 19, 2025 Filed Aug 22, 2025 01:55 UTC | Lumentum Holdings Inc. LITE · Entity 2957 | GrantCommon Stock | 34,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-022695 · form4-08222025_010841.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,597 F1 · kind: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, following vesting, one share of the Issuer's Common Stock. 1/3 of the shares shall vest one year from the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter on the 15th of November, February, May and August, subject to the Reporting Person continuing to be an employee through each such date, or as provided under the Issuer's 2015 Equity Incentive Plan. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 00:41 UTC | FLEX LTD. FLEX · Entity 3085 | GrantOrdinary Shares | 4,713 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-039073 · wk-form4_1754613664.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,208 F1 · shares: On August 6, 2025, the Reporting Person was awarded a total of 4,713 restricted share units ("RSUs") pursuant to the terms of the annual equity award to Non-Employee Directors under the Issuer's Amended and Restated 2017 Equity Incentive Plan as more fully described in the section titled "Fiscal Year 2025 Non-Employee Directors' Compensation" beginning on page 24 of the Issuer's Proxy Statement filed with the SEC on June 24, 2025. Each RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not previously forfeited. The award shall vest in full on the date immediately prior to the date of Issuer's 2026 annual general meeting. F2 · balance_after: Includes 4,713 unvested RSUs, which vest in full on the date immediately prior to the date of Issuer's 2026 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 00:31 UTC | FLEX LTD. FLEX · Entity 3085 | GrantOrdinary Shares | 436 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-035118 · wk-form4_1752712315.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,495 F1 · shares: On July 15, 2025, the Reporting Person was awarded a total of 436 restricted share units ("RSUs") pursuant to the terms of the Issuer's Share Election Program whereby directors elect to receive equity in lieu of cash compensation and as approved by Issuer's Board of Directors and Shareholders on 7/24/2013 and 7/29/2013, respectively. The award was granted for the quarterly period from 04/01/2025 to 06/30/2025. The award vested immediately upon grant. F2 · balance_after: Includes 6,889 unvested RSUs, which vest in full on the date immediately prior to the date of Issuer's 2025 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. Read SEC document |
| June 08, 2025 Filed Jun 10, 2025 23:56 UTC | Astera Labs, Inc. ALAB · Entity 1853 | GrantCommon Stock | 2,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001736297-25-000057 · wk-form4_1749599775.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,645 F1 · shares: These shares represent an award of restricted stock units (RSUs) granted on June 8, 2025 (the Grant Date) under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award vests in full upon the earlier of (i) the first anniversary of the Grant Date or (ii) the date of the next annual stockholder meeting of the Company following the Grant Date, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 700 | $92.64 | $64,844.99 |
DisclosureSEC source: 0001736297-25-000039 · wk-form4_1747685038.xml · nonDerivative · entry 4 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,294 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.2500 to $93.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 1,200 | $91.75 | $110,105.88 |
DisclosureSEC source: 0001736297-25-000039 · wk-form4_1747685038.xml · nonDerivative · entry 3 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,994 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.1700 to $92.1500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 400 | $90.36 | $36,142.00 |
DisclosureSEC source: 0001736297-25-000039 · wk-form4_1747685038.xml · nonDerivative · entry 2 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,194 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.9500 to $90.5500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 200 | $89.07 | $17,814.00 |
DisclosureSEC source: 0001736297-25-000039 · wk-form4_1747685038.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,594 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.6500 to $89.4900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 15, 2025 Filed Apr 17, 2025 00:20 UTC | FLEX LTD. FLEX · Entity 3085 | GrantOrdinary Shares | 766 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-018087 · wk-form4_1744849226.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,059 F1 · shares: On April 15, 2025, the Reporting Person was awarded a total of 766 restricted share units ("RSUs") pursuant to the terms of the Issuer's Share Election Program whereby directors elect to receive equity in lieu of cash compensation and as approved by Issuer's Board of Directors and Shareholders on 7/24/2013 and 7/29/2013, respectively. The award was granted for the quarterly period from 01/01/2025 to 03/31/2025. The award vested immediately upon grant. F2 · balance_after: Includes 6,889 unvested RSUs, which vest in full on the date immediately prior to the date of Issuer's 2025 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 23:49 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 401 | $94.30 | $37,815.30 |
DisclosureSEC source: 0001736297-25-000007 · wk-form4_1740095351.xml · nonDerivative · entry 5 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,794 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.1800 to $94.4800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 23:49 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 499 | $93.29 | $46,549.41 |
DisclosureSEC source: 0001736297-25-000007 · wk-form4_1740095351.xml · nonDerivative · entry 4 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,195 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.8000 to $93.5800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 23:49 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 1,000 | $91.80 | $91,801.00 |
DisclosureSEC source: 0001736297-25-000007 · wk-form4_1740095351.xml · nonDerivative · entry 3 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,694 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.5400 to $92.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 23:49 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 400 | $90.81 | $36,323.00 |
DisclosureSEC source: 0001736297-25-000007 · wk-form4_1740095351.xml · nonDerivative · entry 2 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,694 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.3900 to $91.0300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 23:49 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 200 | $88.56 | $17,712.00 |
DisclosureSEC source: 0001736297-25-000007 · wk-form4_1740095351.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,094 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.2300 to $88.8900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 07, 2025 Filed Feb 12, 2025 00:24 UTC | Lumentum Holdings Inc. LITE · Entity 2957 | GrantCommon Stock | 11,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-003661 · form4-02122025_120210.xml · nonDerivative · entry 2 HURLSTON MICHAEL E. · CIK 0001573338 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,204 F2 · shares: Each share is represented by an RSU. Each RSU represents the contingent right to receive, following vesting, one share of Common Stock of the Issuer. One-fourth of the RSUs will vest on February 7, 2026 and one-sixth of the remaining RSUs shares will vest on May 15, 2026 and each three-month anniversary thereafter, subject to the Reporting Person continuing as an employee, or as provided under the Issuer's 2025 Inducement Equity Incentive Plan. Read SEC document |
| February 07, 2025 Filed Feb 12, 2025 00:24 UTC | Lumentum Holdings Inc. LITE · Entity 2957 | GrantCommon Stock | 103,684 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-003661 · form4-02122025_120210.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,684 F1 · shares: Each share is represented by a restricted stock unit (RSU). Each RSU represents the contingent right to receive, following vesting, one share of Common Stock of the Issuer. One-third of the RSUs will vest on February 7, 2026 and the remaining RSUs shares will vest quarterly over the next eight calendar quarters, subject to the Reporting Person continuing as an employee, or as provided under the Issuer's 2025 Inducement Equity Incentive Plan. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 02:01 UTC | FLEX LTD. FLEX · Entity 3085 | GrantOrdinary Shares | 626 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-001920 · wk-form4_1737165702.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,293 F1 · shares: On January 15, 2025, the Reporting Person was awarded a total of 626 restricted share units ("RSUs") pursuant to the terms of the Issuer's Share Election Program whereby directors elect to receive equity in lieu of cash compensation and as approved by Issuer's Board of Directors and Shareholders on 7/24/2013 and 7/29/2013, respectively. The award was granted for the quarterly period from 10/01/2024 to 12/31/2024. The award vested immediately upon grant. F2 · balance_after: Includes 6,889 unvested RSUs, which vest in full on the date immediately prior to the date of Issuer's 2025 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:26 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 200 | $104.25 | $20,850.00 |
DisclosureSEC source: 0001736297-24-000058 · wk-form4_1733174768.xml · nonDerivative · entry 8 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,294 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:26 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 2,885 | $103.70 | $299,185.17 |
DisclosureSEC source: 0001736297-24-000058 · wk-form4_1733174768.xml · nonDerivative · entry 7 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,494 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.2000 to $104.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:26 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 2,905 | $102.58 | $298,009.13 |
DisclosureSEC source: 0001736297-24-000058 · wk-form4_1733174768.xml · nonDerivative · entry 6 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,379 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $102.1700 to $103.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:26 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 2,500 | $101.59 | $253,979.00 |
DisclosureSEC source: 0001736297-24-000058 · wk-form4_1733174768.xml · nonDerivative · entry 5 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,284 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.1700 to $102.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:26 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 7,414 | $100.30 | $743,659.79 |
DisclosureSEC source: 0001736297-24-000058 · wk-form4_1733174768.xml · nonDerivative · entry 4 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,784 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.1000 to $101.0900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:26 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 35,807 | $99.68 | $3,569,277.57 |
DisclosureSEC source: 0001736297-24-000058 · wk-form4_1733174768.xml · nonDerivative · entry 3 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,198 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.1000 to $100.0900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:26 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 10,319 | $98.63 | $1,017,766.07 |
DisclosureSEC source: 0001736297-24-000058 · wk-form4_1733174768.xml · nonDerivative · entry 2 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,005 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $99.0900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:26 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 5,423 | $97.77 | $530,205.08 |
DisclosureSEC source: 0001736297-24-000058 · wk-form4_1733174768.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,324 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.0900 to $98.0800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2024 Filed Nov 19, 2024 22:25 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 4,306 | $74.64 | $321,399.84 |
DisclosureSEC source: 0000950170-24-128829 · ownership.xml · nonDerivative · entry 2 HURLSTON MICHAEL E. · CIK 0001573338 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 449,509 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. Read SEC document |
| November 17, 2024 Filed Nov 19, 2024 22:25 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-128829 · ownership.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,815 F1 · shares: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2023. F2 · balance_after: Includes 49 shares acquired under the Issuer's Employee Stock Purchase Plan on September 15, 2024. Read SEC document |
| October 15, 2024 Filed Oct 16, 2024 01:21 UTC | FLEX LTD. FLEX · Entity 3085 | GrantOrdinary Shares | 763 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-042883 · wk-form4_1729041705.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,667 F1 · shares: On October 15, 2024, the Reporting Person was awarded a total of 763 restricted share units ("RSUs") pursuant to the terms of the Issuer's Share Election Program whereby directors elect to receive equity in lieu of cash compensation and as approved by Issuer's Board of Directors and Shareholders on 7/24/2013 and 7/29/2013, respectively. The award was granted for the quarterly period from 07/01/2024 to 09/30/2024. The award vested immediately upon grant. F2 · balance_after: Includes 6,889 unvested RSUs, which vest in full on the date immediately prior to the date of Issuer's 2025 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. Read SEC document |
| August 27, 2024 Filed Aug 28, 2024 20:24 UTC | Astera Labs, Inc. ALAB · Entity 1853 | Exercise / conversionStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001736297-24-000026 · wk-form4_1724876693.xml · derivative · entry 2 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2031-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vests in 24 equal monthly installments after June 15, 2020, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on June 17, 2021. Read SEC document |
| August 27, 2024 Filed Aug 28, 2024 20:24 UTC | Astera Labs, Inc. ALAB · Entity 1853 | Exercise / conversionCommon Stock | 40,000 | $0.31 | $12,400.00 |
DisclosureSEC source: 0001736297-24-000026 · wk-form4_1724876693.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2024 Filed Aug 20, 2024 23:10 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 29,763 | $76.38 | $2,273,297.94 |
DisclosureSEC source: 0000950170-24-099305 · ownership.xml · nonDerivative · entry 3 HURLSTON MICHAEL E. · CIK 0001573338 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,336 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units, market stock units, and restricted stock units. Read SEC document |
| August 17, 2024 Filed Aug 20, 2024 23:10 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 31,509 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-099305 · ownership.xml · nonDerivative · entry 2 HURLSTON MICHAEL E. · CIK 0001573338 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 483,099 F2 · shares: Reflects shares released in connection with the vesting of performance stock units and market stock units granted on August 17, 2021, August 17, 2022, and August 17, 2023. Read SEC document |
| August 17, 2024 Filed Aug 20, 2024 23:10 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 42,472 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-099305 · ownership.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 451,590 F1 · shares: One-third of the total number of restricted stock units shall vest on the first anniversary date following the vesting commencement date of August 17, 2024, and one-twelfth of the total number of restricted stock units shall vest each quarter thereafter until fully vested on August 17, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.